🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess whether patients who are likely to f...
Status
Unknown
Location
BC Cancer Agency
Start Date
2006-08
Trial ID
NCT00324467
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Sun City Clinical Research- Site Number : 8400247
Start Date
2024-12-18
Trial ID
NCT06736041
Treatments Being Tested
This is an open-label, multicenter, Phase I/II study to assess the safety, ...
Status
Terminated
Location
TGen Clinical Research Srvs
Start Date
2011-03-16
Trial ID
NCT01296555
Treatments Being Tested
The objective of CROWN CORONATION is the prevention of symptomatic COVID-19...
Status
Completed
Location
Washington University School of Medicine
Start Date
2020-09-04
Trial ID
NCT04333732
Treatments Being Tested
The goal of this study is to evaluate efficacy and safety of the combinatio...
Status
Terminated
Location
Diakonie Krankenhaus Bremen
Start Date
2010-11
Trial ID
NCT02983097
This is a modified single-blind, randomized, parallel-group, comparative, m...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00422292
The purpose of this study is to compare two measles, mumps and rubella conj...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-03
Trial ID
NCT00861744
RATIONALE: Antithymocyte globulin, clofarabine, and rituximab may stop the ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2008-01
Trial ID
NCT00617929
Treatments Being Tested
The study was designed to test the following hypotheses: In patients with ...
Status
Unknown
Location
Hopital Universitaire
Start Date
2013-01
Trial ID
NCT01820598
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Alaska Regional Hospital Cancer Center
Start Date
2006-08
Trial ID
NCT00376961
Treatments Being Tested